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Graph 1. Bone strength was assessed in control (C) group, animals
receiving Zoledronate (Z), those animals sleep deprived (SD), and
sleep deprived animals receiving Zoledronate (SDZ). There were no
significant differences between the groups (P>0.05).
The purpose of this study was to determine the effects of sleep deprivation
on bone metabolism with and without Zoledronate treatments. Zoledronate
was shown to increase both strength (P>0.05) and distal femur trabecular
thickness (P<0.05). The study was conducted with a total of 29 animals
which made the statistical analysis sensitive to variance (Graphs 1 and 2).
Our results may have been more illuminating had we used a greater number
of animals. Explanations for the increased bone strength and distal femur
trabecular thickness of subjects in the sleep-deprived groups were derived
based on Wolff’s Law stating that mechanical load from the environment can
induce bone remodeling. It was believed that the sleep-deprived rats were
subjected to training effects from extended periods of standing on the
narrow pillars (Figure 1) which would strengthen the trabeculae and cortical
bone in response to the additional load. Great lengths were taken to
construct a trial which equated the relative lifespan of rats to humans as
determined by Sengupta where the relative age for humans during a
postmenopausal period over 1 year was equal to 11.8 days in rats[7]. It was
determined based on the relative proportions that a 5-week trial would
simulate the common 3-year design of many bisphosphonate clinical trials. It
should be noted that even though the relative age between humans and rats
was considered, rats may not be the preferred model for human physiology.
Future studies may be fruitful if a different animal model is used. There is
much work remaining that examines the consequences of sleep deprivation
in postmenopausal women.
Wistar female rats (mean weight of
341g) were ovariectomized to
induce estrogen deficiency. These
rats were randomly separated into
four groups. The control (C, n=6)
group was injected with 0.9%
saline before the study and allowed
12 hours light and 12 hours dark.
The Zoledronate (Z, n=9) group
received an intraperitoneal injection
Approximately 200 million people worldwide suffer from osteoporosis, a
disease characterized by the degradation of bone leading to decreased
bone strength and bone mineral density (BMD) and increased risk of
fracture[1]. Data suggested that 25% of Americans reported insufficient sleep
(>6 hr over more than 15 days/month),[2] with individuals who logged less
than 6 hours of sleep per night suffering a significantly lower BMD than
those who reported 6-8 hours of sleep per night[3]. Heightened adverse
physiological effects, including lowered BMD, resulting from sleep
deprivation were identified in menopausal females[4]. With nearly a 2-fold
increase in the number of females who have filled executive level business
positions, the physiological response to the heightened levels of stress may
leave females subject to greater bone health concerns.[5] Previously, our lab
examined the BMD of sleep deprived animals, but this work focused upon
trabecular thickness as an additional tool in the evaluation of osteoporosis.
BMD can be evaluated via trabecular thickness. To minimize the bone
degradation occurring in sleep-deprived individuals, bisphosphonate-based
medications like Zoledronate are often prescribed. Zoledronate works to
inhibit osteoclastic activity and function by blocking a portion of the
mevalonate pathway through the inhibition of farnesyl pyrophosphate
synthase which restricts the prenylation of certain GTPases[6]. These
GTPases alter the signaling for osteoclastic function, thus reduce the bone
degrading effects of osteoporosis[6]. The purpose of this study was to
evaluate the consequences of sleep deprivation on bone metabolism with
and without the protective effects of Zoledronate in sleep-deprived,
estrogen-deficient rats.
(50 ug/kg) of Zoledronate at the same time One sleep-deprived group (SD,
n=9) was housed in the MMPM tank (Figure 1) that prevented sleep for 18
hours, then moved to a sleep chamber for 6 hours. A second sleep-deprived
group (SDZ, n=9) was treated as the SD group but with the addition of 50
𝜇g/kg Zoledronate before the study. Tibiae and femora were collected,
wrapped in saline-soaked gauze and stored at -80 F. Subsequently, a DEXA
scan, and a 3-point bending test were performed.
Graph 2. Distal Femur Trabecular Thickness was assessed in control
(C) group, animals receiving Zoledronate (Z), animals who were sleep
deprived (SD), and sleep-deprived animals who received Zoledronate
(SDZ). The SDZ group showed significance *(P=0.05) compared to the
SD group.
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